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ABSTRACT
The role of interleukin (IL)-4 in the development of
allergen-induced airway inflammation and bronchial
hyperresponsiveness (BHR) is still controversial. To
investigate the role of IL-4 in the development of
antigen-induced airway inflammation and BHR, we
used two different inbred IL-4 gene-knockout mice;
one was BALB/c, which is known to be a high IgE
responder, and the other was C57BL/6, known to be a
low IgE responder and a lower responder to acetyl-
choline (ACh) in the airways. Mice were immunized
with antigen at intervals of 12 days. Starting 10 days
after the second immunization, mice were exposed to
antigen three times every fourth day. Twenty-four hours
after the last antigen challenge, bronchial responsive-
ness to ACh was measured and bronchoalveolar
lavage was performed. In sensitized BALB/c mice,
repeated aeroallergen challenge induced dramatic
eosinophilia in the airways and severe increases in
bronchial responsiveness to intravenous ACh, along
with increases in serum antigen-specific IgE. In contrast,
immunized C57BL/6 mice, after antigen provocation,
developed a minor influx of eosinophils into the
airways and only moderate increases in bronchial
responsiveness without antigen-specific IgE in serum,
indicating that the genetic background influenced not
only IgE synthesis, but also the degree of airway
inflammation and BHR. Moreover, disruption of the 
IL-4 gene in both strains of mice abolished allergen-
induced BHR, airway eosinophilia and IgE response.
Together, these findings suggest that the differences in
genetic background can directly influence the patho-
physiology of bronchial asthma, including the role of
IgE, and that IL-4 has a crucial role in the development
of allergen-induced BHR independent of genetic back-
ground.
Key words: bronchial hyperresponsiveness, eosin-
ophils, IgE, interleukin-4, mice.
INTRODUCTION
While bronchial hyperresponsiveness (BHR) is a charac-
teristic feature in most asthmatics and correlates with
the severity of disease,1 its precise mechanism remains
unclear. Recent investigations have demonstrated that
allergen-specific CD4+ T helper 2 (Th2)-type lympho-
cytes and the cytokine interleukin (IL)-4 play important
roles in the development of airway eosinophilic inflam-
mation and BHR.2–4 Interleukin-4 is thought to be
involved in allergic reactions, because it induces the dif-
ferentiation of naive CD4+ T lymphocytes into Th2-type
cells,5 mast cell proliferation6 and also IgE synthesis.7 In
allergic bronchial asthma, IgE is thought to play an
important role in the generation of mediators and in the
development of BHR.
Results from recent studies regarding the role of IL-4 in
the onset of allergen-induced BHR are still conflicting.8–12
Brusselle et al. reported that aeroallergen-induced airway
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inflammation and BHR are dependent on IL-4 in gene-
disrupted mice.8 In addition, Corry et al. Renz et al. and
Gavett et al. have reported that IL-4 is an important factor
in the onset of BHR in BALB/c9,10 and A/J11 mice. In con-
trast, a more recent study has demonstrated that IL-4 is
not involved in the development of BHR in IL-4 gene-
knockout (KO) mice.12 Thus, the role of IL-4 in the
development of BHR remains equivocal and the reason
for these conflicting findings is still not understood.
Strategies of gene manipulation such as ‘knockout’ or
‘transgenic’ are important methods to understand the role
of a certain molecule, especially in mice. However, recent
reports indicate that the genetic background may, in some
cases, directly influence the interpretation of the effect of
gene disruption.13–15 With regard to bronchial responsive-
ness to stimuli, several investigators have studied different
strains of inbred mice for differences in airway respon-
siveness.16–18 Levitt and Mitzner initially reported strain
differences in responsiveness. Of nine common inbred
mice, A/J and AKR/J mice showed the greatest respon-
siveness to acetylcholine (ACh) injected exogeneously and
BALB/c showed a moderate responsiveness, whereas
C57BL/6, SJL/J and C3H/HeJ mice exhibited the least
responsiveness.16 In addition to airway responsiveness, it
has also been reported, especially in mice, that the pro-
duction of IgE depends on the genetic background.19,20
However, no studies to date have investigated the role
of IL-4 by using different strains of mice in the same
experimental protocol. Thus, the purpose of present study
was to clarify the role of IL-4 in the development of
aeroallergen-induced airway inflammation and BHR
using two different strain backgrounds of IL-4 gene-KO
mice, namely BALB/c and C57BL/6 mice. Moreover, we
investigated whether the genetic background influenced
the phenotype of asthmatic responses and directly
affected the role of IL-4.
METHODS
Animals
Seven-week-old male IL-4 KO mice (BALB/cJ21 and
C57BL/6J22 background) and age-matched male wild-
type animals were purchased from Jackson Laboratory
(Bar Harbor, ME, USA). Animals were housed in plastic
cages in an air-conditioned room at 22 ± 1°C with a 
relative humidity of 60 ± 1%, were fed a standard labo-
ratory diet and were given water ad libitum. Experiments
were performed following the 1987 guidelines for the
care and use of experimental animals of the Japanese
Association for Laboratory Animals Science.
Agents
Ovalbumin (OA; Seikagaku Kogyo, Tokyo, Japan), acetyl-
choline chloride (ACh; Nacalai Tesque, Kyoto, Japan),
bovine serum albumin (BSA; Seikagaku Kogyo), Turk solu-
tion (Wako Pure Chemical Industries Ltd, Osaka, Japan),
pancronium bromide (Sigma Chemical Co., St Louis, 
MO, USA), pentobarbital sodium (Abbott Laboratories,
Chicago, IL, USA), disodium ethylenediaminetetraacetic
acid (EDTA-2Na; Nacalai Tesque), Diff-Quick solution
(International Reagent Corp., Kobe, Japan), monoclonal
antimouse IgE antibody (LO-ME-3; Serotek Co. Ltd,
Oxford, UK), peroxidase-labeled polyclonal antimouse IgE
(Nordic Immunological Laboratories, Tilburg, Netherlands)
and peroxidase-conjugated streptavidin (Dakopatts a/s,
Glostrup, Denmark) were purchased commercially.
Sensitization and antigen challenge
Mice were actively sensitized by intraperitoneal injections of
50 m g OA with 1 mg alum on days 0 and 12. Starting on
day 22, mice were exposed to OA (1% w/v diluted in sterile
physiological saline) for 30 min, three times every 4th day
according to previously reported methods.23 Non-
sensitized animals received 1 mg alum and were exposed
to saline in a similar manner. In a previous study, we com-
pared the effect of sensitization on airway function and
airway inflammation in saline-exposed animals; there were
no significant differences in these parameters,24 thus we
chose two groups for the present study. The aerosol 
(particle size 2.0–6.0 m m) was generated by a nebulizer
(Ultrasonic nebulizer TUR-3200; Nihon Koden, Tokyo,
Japan) driven by filling a perspex cylinder chamber 
(5.5 cm diameter, 12 cm height) with a nebulized solution.
Measurement of immunoglobulins
Immediately prior to the last antigen challenge, blood
was collected and sera were obtained by centrifugation
and were stored at –80°C. Antigen-specific and total
IgE in the mouse serum was measured using the
enzyme-linked immunosorbent assay (ELISA) described
previously.25 Briefly, polyclonal IgE or serum OA-
specific IgE was measured by coating monoclonal rat
antimouse IgE antibody (LO-ME-3) at a concentration
of 5 m g/mL. After blocking with 1% BSA, serum dilutions
were incubated for 1 h followed by peroxidase-labeled
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polyclonal antimouse IgE or biotinylated-OA and perox-
idase-conjugated streptavidin, respectively. Sequentially
diluted monoclonal antidinitrophenol IgE or monoclonal
anti-OA IgE were used as standards, respectively.
Optical densities of the enzymatic reactions were read
using an automatic ELISA plate reader (Titertek Multiscan
MCC/340; Lab systems Oy, Helsinki, Finland) at 450 nm
(690 nm). Each detection limit was 10 ng/mL.
Bronchoalveolar lavage study
To evaluate airway inflammation, we studied the accumu-
lation of inflammatory cells in bronchoalveolar lavage
fluid (BALF). Experiments were performed according to
previously described methods.26 After measurement of
lung function parameters, animals were killed with an
intraperitoneal injection of sodium pentobarbitone (100
mg/kg). The trachea was cannulated and the air lumen
was washed four times with 1 mL calcium- and magne-
sium-free phosphate-buffered saline (PBS) containing
0.1% BSA and 0.05 mmol/L EDTA-2Na. This procedure
was repeated three times (total volume 3 mL, recovery 
> 85%). Bronchoalveolar lavage fluid from each animal
was pooled in a plastic tube, cooled on ice and cen-
trifuged (150 g) at 4°C for 10 min. Cell pellets were
resuspended in the same buffer (1 mL). Bronchoalveolar
lavage fluid was stained with Türk solution and the
number of nucleated cells was counted in a Bürker
chamber. A differential count was made on a smear 
prepared with a cytocentrifuge (Cytospin II; Shandon,
Cheshire, England) and stained with Diff-Quick solution
(based on standard morphologic criteria) of at least 300
cells (magnification · 500).
Measurement of airway function
Measurement of bronchial responsiveness to ACh was
performed by modification of methods described previ-
ously.26 Briefly, to measure bronchial responsiveness to
ACh, mice were anesthetized with sodium pentobarbitone
(60 mg/kg, i.p.) and the jugular vein was cannulated for
intravenous injection of ACh. Mice were injected with 
pancronium bromide (0.1 mg/kg, i.v.) to suppress sponta-
neous respiration and were ventilated with a rodent
ventilator (New England Medical Instruments Inc.,
Medway, MA, USA) with oxygen-supplemented air at 
60 strokes/min at a stroke volume of 0.6 mL/animal.
Bronchoconstriction was measured according to the 
overflow method, using a bronchospasm transducer 
(Ugo Basile 7020, Milan, Italy) connected to the tracheal
cannula. To measure bronchial responsiveness to ACh,
changes in respiratory overflow volume were measured
using increasing doses of ACh. The increase in respira-
tory overflow volume induced by ACh was represented as
a percentage of the maximal overflow volume (100%)
obtained by clamping the tracheal cannula. Area under
the curve (AUC) was calculated from the dose–response
curve for ACh (range 125–2000 m g/kg).25
Histologic study
Mice were killed 24 h after the third antigen inhalation
and whole lungs were distended by injection of 10%
buffered formalin via the trachea, excised and immersed
in the same fixative with the trachea clamped for 24 h.
Tissues were sliced and embedded in paraffin and 6 m m
sections were stained with hematoxylin and eosin for light
microscopic examination.
Statistical analyses
Data are presented as the mean ± SEM. Significance
between saline- and OA-inhaled animals, or between
wild-type and IL-4 KO animals, was estimated using 
the two-tailed Student’s t-test or the Aspin–Welch test  
P < 0.05 was considered significant.
RESULTS
IgE responses after systemic immunization
and aeroallergen challenge
To investigate the role of IL-4 and the effect of genetic
background in antigen-induced IgE production, serum
antigen-specific IgE and total IgE levels were measured.
Serum was obtained from mice on day 30, immediately
prior to the last antigen provocation.
Sensitization and repeated exposure to OA caused 
significant increases in the level of antigen-specific and
total IgE in BALB/c mice (Table 1). In contrast with
BALB/c mice, antigen-specific IgE was below the detec-
tion limit (10 ng/mL) and there was no significant
increase in serum total IgE on day 30 in OA-inhaled
C57BL/6 mice, although transient increases in both IgE
after the first systemic immunization (on day 12) were
observed (total IgE 1995.7 ± 255.0 vs saline inhaled
111.6 ± 1.3 ng/mL; specific IgE 122.8 ± 18.2 vs
saline inhaled < 10 ng/mL). As expected, disruption of
the IL-4 gene in both strains showed no increases in
antigen-specific IgE and polyclonal IgE. In contrast with
OA-sensitized and exposed mice, serum OA-specific IgE
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Fig. 1 Allergen-induced in-
creases in the (a,b) total number of
leukocytes, (c,d) eosinophils and
(e,f) lymphocytes in bronchoalveo-
lar lavage fluid of wild-type and 
interleukin-4 knockout (IL-4 KO)
BALB/c (a,c,e) and C57BL/6
(b,d,f ) mice. Results are the mean
± SEM of six to eight mice in 
each group. ND, not detected.
*P < 0.05, **P < 0.01 compared
with the saline group; †P < 0.05,
††P < 0.01 and †††P < 0.001
compared with the ovalbumin
(OA) group of wild-type mice; 
(h), saline; (j), OA.
Table 1 Serum total IgE and antigen-specific IgE levels in interleukin-4 knockout mice
Sensitization Antigen provocation Total IgE OA-specific IgE
Strain Genotype (days 0 and 12) (days 22, 26, 30) (ng/mL) (ng/mL)
BALB/c Wild-type Alum Saline 386.67 ± 93.55 ND
Wild-type OA OA 1925.53 ± 285.99** 101.69 ± 7.16
IL-4 KO Alum Saline 47.13 ± 25.56†† ND
IL-4 KO OA OA 35.22 ± 17.99††† ND
C57BL/6 Wild-type Alum Saline 146.03 ± 19.38 ND
Wild-type OA OA 194.43 ± 20.98 ND
IL-4 KO Alum Saline ND ND
IL-4 KO OA OA ND ND
Results are the mean ± SEM of six to eight mice in each group. **P < 0.01 compared with the alum–saline group; ††P < 0.01, †††P < 0.001
compared with the wild-type group.
OA, ovalbumin; ND, not detected (< 10 ng/mL).
remained below the detection limit (< 10 ng/mL) in both
saline-injected and -exposed groups.
Antigen-induced airway eosinophilic 
inflammation
In a previous study, we reported the time course of
antigen-induced airway eosinophilia.27 The number of
eosinophils and lymphocytes in BALF increased signifi-
cantly after three antigen inhalations and these levels
reached a plateau approximately 24–48 and 8 h after the
last antigen inhalation in sensitized mice, respectively.27
Repeated antigen challenge in actively sensitized BALB/c
mice to aerosolized OA induced a significant increase in
the number of eosinophils and a tendency for an increase
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Fig. 2 Histologic analysis of
lung sections from (a,b,e,f)
wild-type mice and (c,d,g,h)
interleukin-4 knockout (IL-4
KO) BALB/c (a–d) and
C57BL/6 (e–h) mice 24 h after
antigen challenge. (a,c,e,g)
Saline-injected and saline-
exposed groups; (b,d,f,h)
immunized with ovalbumin
(OA) and OA-inhaled groups.
(a,c,e,g) Normal features in the
control group exposed to saline
(original magnification · 50);
(b,f) after immunization and
inhalation of OA, inflammatory
infiltrates, especially eosin-
ophils and mononuclear cells,
are present around the peri-
bronchial and perivascular
regions in wild-type mice, but
the degree of infiltration was
more severe in BALB/c mice
rather than in C57BL/6 mice
(original magnification · 50);
(d,h) after immunization and
repeated antigen provocation,
a few eosinophils and mononu-
clear leukocytes are present in
IL-4 KO mice (original magnifi-
cation · 50).
in the number of lymphocytes in BALF compared with that
in saline-injected mice (Fig. 1). In C57BL/6 mice, the
increases in the number of total leukocytes, eosinophils
and lymphocytes after allergen provocation were one-fifth
to one-half less than those in BALB/c mice. In contrast with
wild-type mice, the number of total leukocytes, eosinophils
and lymphocytes was significantly reduced in IL-4 KO mice
and antigen-induced airway inflammation was clearly
decreased compared with wild-type mice (Fig. 1). The
number of macrophages and neutrophils also tended to
increase in OA-exposed mice, but there was no significant
difference between the saline- and OA-exposed groups
and the disruption of the IL-4 gene did not influence these
responses (data not shown).
Histologic analysis of lungs from both saline-exposed
wild-type and IL-4 KO mice showed normal lung histol-
ogy (Fig. 2a,c,e,g). Similar to the bronchoalveolar lavage
(BAL) study, histologic sections of lung tissue from OA-
exposed wild-type mice exhibited pulmonary eosinophilic
inflammation, especially in BALB/c background mice.
Infiltrating eosinophils and mononuclear cells were
mainly observed in the peribronchial and perivascular
regions of the lungs in wild-type mice (Fig. 2b,f). In con-
trast, after aeroantigen challenge in IL-4 KO mice, airway
inflammation, including eosinophils and lymphocytes,
was clearly attenuated compared with wild-type mice
regardless of the genetic background (Fig. 2d,h).
Bronchial responsiveness to ACh after 
repeated antigen provocation
To investigate the effect of IL-4 gene disruption and genetic
background on airway function, bronchial responsiveness
to ACh was examined 24 h after the last allergen chal-
lenge. Figure 3 shows the area under the dose–response
curve of bronchial responsiveness to ACh after repeated
antigen inhalations in both wild-type and IL-4 KO mice. In
the saline-exposed groups of both animal strains, BHR to
ACh was not observed and there was no significant differ-
ence between wild-type and IL-4 KO mice or between
BALB/c and C57BL/6 mice in the group of saline-inhaled
mice. Repeated antigen provocation significantly increased
the AUC dose–response to ACh (Fig. 3) in wild-type mice,
although BHR observed in BALB/c mice was clearly higher
than in C57BL/6 mice. In contrast with wild-type mice,
bronchial responsiveness to ACh after antigen challenge
was not observed in IL-4 KO mice and the degree of
bronchial responsiveness to ACh was not significantly dif-
ferent from that of saline-exposed animals (Fig. 3).
DISCUSSION
In the present study, we have demonstrated that repeated
antigen inhalation causes a marked increase in the
number of eosinophils and lymphocytes in the BALF and
airway tissues of both sensitized wild-type mice, but not in
IL-4 KO mice. Furthermore, antigen-induced BHR was
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Fig. 3 Airway responsiveness to acetylcholine (ACh) in wild-
type and interleukin-4 knockout (IL-4 KO) mice 24 h after
repeated antigen challenge. (a) BALB/c mice; (b) C57BL/6
mice. Area under the curve (AUC) was calculated from the
results of the dose–response curve for ACh. Results are the
mean ± SEM of six to eight animals in each group. *P < 0.05,
***P < 0.01 compared with the saline group; †P < 0.05 and
†††P < 0.001 compared with the ovalbumin (OA) group of
wild-type mice; (h), saline; (j), OA.
observed in wild-type mice but not in IL-4 KO mice, while
the degree of these responses was different between the
strains. These findings indicate that IL-4 plays a pivotal
role in the development of both allergen-induced airway
eosinophilia and BHR. Moreover, the experiments also
demonstrated that the genetic background could directly
affect the phenotype of antigen-induced BHR.
The role of IL-4 in the development of antigen-induced
BHR is still not clearly defined. Corry et al. reported that
neutralization of IL-4 with monoclonal antibody when
administered during immunization and antigen challenge
clearly inhibited IgE production, airway eosinophilia and
BHR in BALB/c mice.9 It was also reported by Brusselle 
et al. that deficiency of the IL-4 gene resulted in a defect
of the IgE response, airway eosinophilia or BHR to 
5-hydroxytryptamine in 129 · C57BL/6 F1 mice com-
pared with wild-type C57BL/6 mice.8 In contrast, Hogan
et al. recently demonstrated that BHR was still observed
after antigen provocation in 129 · C57BL/6 F1 back-
ground IL-4 KO mice, although airway eosinophilia and
IgE responses were impaired.12 The reason for these 
discrepancies is not clear, but there are at least two expla-
nations; one is due to the genetic background and the
other is due to differences in the experimental protocol.
Recent investigations suggest that genetic background
can influence the outcome and the interpretation of
results.13–15 To clarify the role of IL-4, we used two strains
of IL-4 KO mice, namely BALB/c and C57BL/6. As a
result, deficiency of IL-4 abolished antigen-induced
airway eosinophilia and BHR independent of the genetic
background, although the severity of the inflammatory
and immune responses was quite different between the
two strains. The present findings strongly indicate that 
IL-4 is a critical factor for the development of BHR in 
this model. Moreover, we recently examined the role of
several molecules for the onset of airway inflammation
and BHR using 129 · C57BL/6 F1 mice compared with
C57BL/6 F5 mice and the data obtained were quite 
different between these mice (H Tanaka and H Nagai,
unpubl. obs., 1997), suggesting that strain differences
should be given more attention when considering the
involvement of functional molecules if the technique of
gene manipulation is used.
Alternatively, with the differences in the experimental
protocol, the degree of airway inflammation, cytokine
production and IgE responses were quite different
between the investigations, even when identical mouse
strains were used. Hogan et al.28 immunized BALB/c mice
using the same protocol as that used in the present study
on days 0 and 12 and aerosolized three times a day,
every second day thereafter, for the next 8 days. The
number of eosinophils in BALF was approximately 
3 · 106, which was approximately 60% of the total leuko-
cytes and was 10-fold more than that in our model; 
in addition, antigen-specific IgE responses were also
approximately 10-fold greater. These findings suggest
that the frequency of allergen challenge may influence
the severity of inflammatory immune responses and the
degree of BHR and could induce the different phenotypes
of pathophysiology of allergic asthma.29
In the present study, we compared two distinct inbred
mouse strains, BALB/c and C57BL/6 mice, which are
generally used in mouse asthma models. In sensitized
BALB/c mice, repeated antigen challenge induced airway
eosinophilia, increases in polyclonal and antigen-specific
IgE in sera and BHR in response to intravenous choliner-
gic stimuli. In contrast, the increases in antigen-specific
and polyclonal IgE were observed after the first immu-
nization in C57BL/6 mice, but the level of specific and
total IgE decreased after the second immunization and
then could not be detected at all until immediately prior
to the first antigen challenge. Moreover, in the present
study, we did not measure the levels of IL-4 in BALF after
repeated antigen challenge. However, according to our
previous data, the levels of IL-4 in BALF 24 h after the last
antigen challenge in BALB/c mice were two- to three-fold
higher than that of C57BL/6 mice.27,30 Under these con-
ditions, repeated antigen provocation can still induce
BHR and mild eosinophilia in the airways of C57BL/6
mice, although these parameters were weaker than those
of BALB/c mice. These findings indicate that the genetic
background can influence differences in immune and
inflammatory responses.20,29 First, C57BL/6 mice are
known to be genetically deficient in several functional
molecules.31–34 Among these, IL-9 is one of the candidate
factors, which may explain these differences. Interleukin-9
is known to be a growth factor for mast cells and T cells,
produced by mainly Th2 cells.35 Recently, Levitt et al.
reported that intratracheal injection of murine recombi-
nant IL-9 induced increases in serum total IgE levels and
airway eosinophilia by enhancing the expression of IL-5
receptor a chain in C57BL/6 mice,36 which is naturally
deficient in IL-9.31 Thus, the defects of IgE responses and
impaired airway eosinophilia in C57BL/6 mice are
related, at least in part, to the deficiency of IL-9, although
a study to investigate the contribution of IL-9 is required.
In addition, we have previously reported that mast cells
are important for the development of BHR, but not airway
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eosinophilia.37 The C57BL/6 strain is also genetically
deficient in a protease 732,33 and secretory phospholipase
A234 of mast cells. Moreover, strain differences in
bronchial responsiveness to spasmogenic stimuli have
also been reported.16,17 As for the degree of BHR, these
molecules could be involved in the onset of BHR in this
model.
Alternatively, small increases may explain the differ-
ences in the degree of BHR that small increases in
inflammatory leukocytes (e.g. eosinophils and lympho-
cytes) and Th2 cytokines, including IL-4 and IL-5 in the
airways in the absence of IgE, are enough to induce 
BHR in response to a cholinergic stimuli in C57BL/6
mice. Recently, Drazen et al. proposed that BHR could 
be induced by two distinct mechanisms; one could 
be mediated by the IgE–mast cell pathway, whereas 
the other could be induced by the IL-5–eosinophil
pathway.38 Taken together, the relative contribution of
these mechanisms to the induction of allergen-induced
airway inflammation and BHR could be different in each
mouse strain.
In conclusion, we have demonstrated that deficiency of
the IL-4 gene abrogates the IgE responses, airway eosi-
nophilic inflammation and BHR and that these findings are
independent of the genetic background of the mice used,
at least in our model. Furthermore, the present findings
suggest that genetic background can directly influence the
phenotype of the pathophysiology of allergic asthma.
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